Expert consensus opinion in treatment of epilepsy

Chinese Journal of Neurology

Volumn 44, Issue 1, 2011, Pages 56-64

  Hong, Zhen ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Drug therapy; Epilepsy; Questionnaires

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; TOPIRAMATE; VALPROIC ACID;

ABSENCE; ADD ON THERAPY; ADULT; ARTICLE; CHINA; COMORBIDITY; COMPLEX PARTIAL SEIZURE; CONSENSUS; EMERGENCY WARD; EPILEPSY; FEMALE; GENERALIZED EPILEPSY; HUMAN; IDIOPATHIC GENERALIZED EPILEPSY; LIVER DYSFUNCTION; LIVER FUNCTION; MALE; MONOTHERAPY; MYOCLONUS SEIZURE; PREGNANT WOMAN; QUESTIONNAIRE; RATING SCALE; SECONDARILY GENERALIZED TONIC CLONIC SEIZURE; SIMPLE PARTIAL SEIZURE; SYMPTOMATIC LOCALIZATION RELATED EPILEPSY; TONIC CLONIC SEIZURE;

EID: 84860612694     PISSN: 10067876     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1006-7876.2011.01.015     Document Type: Article

References (20)

1. Karceski S, Morrell M J, Carpenter D. Treatment of epilepsy in adults: expert opinion, 2005. Epilepsy Behav, 2005, 7 Suppl 1: S1-64.
2. French J A, Kanner A M, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I. Treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology, 2004, 62: 1252-1260.
3. Perucca E, Gram L, Avanzini G, et al. Antiepileptic drugs as a cause of worsening seizures. Epilepsia, 1998, 39: 5-17.
4. Kwan P, Brodie M J. Early identification of refractory epilepsy. N Engl J Med, 2000, 342: 314-319.
5. Marson A G, Al-Kharusi A M, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet, 2007, 369: 1016-1026.
6. Beghi E, Gatti G, Tonini C, et al. Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomized, pragmatic controlled trial. Epilepsy Res, 2003, 57: 1-13.
7. Kwan P, Brodie M J. Epilepsy after the first drug fails: substitution or add-on? Seizure, 2000, 9: 464-468.
8. Hauser W A. Seizure disorders: the changes with age. Epilepsia, 1992, 33 Suppl 4: S6-14.
9. Wallace H, Shorvon S, Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet, 1998, 352: 1970-1973.
10. Faught E. Monotherapy in adults and elderly persons. Neurology, 2007, 69 (24 Suppl 3): S3-S9.
11. Stephen L J, Kelly K, Mohanraj R, et al. Pharmacological outcomes in older people with newly diagnosed epilepsy. Epilepsy Behav, 2006, 8: 434-437.
12. Bogliun G, Beghi E, Crespi V, et al. Anticonvulsant drugs and bone metabolism. Acta Neurol Scand, 1986, 74: 284-288.
13. Rantanen K, Timonen S, Hagström K, et al. Social competence of preschool children with epilepsy. Epilepsy Behav, 2009, 14: 338-343.
14. Hermann B P, Jones J E, Sheth R, et al. Growing up with epilepsy: a two-year investigation of cognitive development in children with epilepsy. Epilepsia, 2008, 49: 1847-1858.
15. Forsgren L. Prevalence of epilepsy in adults in northern Sweden. Epilepsia, 1992, 33: 450-458.
16. Schmitz B. Effects of antiepileptic drugs on mood and behavior. Epilepsia, 2006, 47 Suppl 2: S28-33.
17. Meador K J. Cognitvie and memory effects of the new antiepileptic drugs. Epilepsy Res, 2006, 68: 63-67.
18. Browne T R. Renal disorders//Ettinger AB, Devinsky O. Managing Epilepsy and Co-Existing Disorders. Boston: Butterworth-Heinemann, 2002: 49-62.
19. Farhidvash F, Singh P, Abou-Khalil B, et al. Patients visiting the emergency room for seizures: insurance status and clinic follow-up. Seizure, 2009, 18: 644-647.
20. Krumholz A. Driving issues in epilepsy: past, present and future. Epilepsy Curr, 2009, 9: 31-35.